Drug Trial Radar · NCT04875169
Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Jun 1, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
336
Actual
Start
Apr 30, 2021
Primary completion
Aug 12, 2022
Study completion May 23, 2023
Sponsor
- Lead sponsor
- Reistone Biopharma Company LimitedIndustry
- Sponsor type
- Industry
- First posted
- May 6, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 330 subjects aged 12 to 75 years old with moderate to severe atopic dermatitis.
Conditions
- Atopic Dermatitis
Interventions
Core Treatment Active Experimental: SHR0302 Dose#1Drug
Drug: SHR0302 Oral tablets taken once daily (QD) for 16 weeks
Core Treatment Active Experimental: SHR0302 Dose#2Drug
Drug: SHR0302 Oral tablets taken once daily (QD) for 16 weeks
Core Treatment Placebo Comparator: PlaceboDrug
Drug: Placebo Oral tablets taken once daily (QD) for 16 weeks
Extension Treatment Active Experimental: SHR0302 Dose#1Drug
Drug: SHR0302 Oral tablets taken once daily (QD) for 36 weeks
Extension Treatment Active Experimental: SHR0302 Dose#2Drug
Drug: SHR0302 Oral tablets taken once daily (QD) for 36 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Investigator's Global Assessment (IGA) score of 0/1 at Week 16Time frame: 16 Weeks
- Eczema Area and Severity Index (EASI 75) at Week 16Time frame: 16 Weeks
Locations
52 sites in 2 countries. Site status is shown where the registry gives one.
Dermatology Research Institute Inc.
Calgary, Alberta, Canada
Dr Chih-ho Hong Medical Inc.
Surrey, British Columbia, Canada
Enverus Medical Research
Surrey, British Columbia, Canada
Wiseman Dermatology Research
Winnipeg, Manitoba, Canada
CCA Medical Research
Ajax, Ontario, Canada
SKiN Health
Cobourg, Ontario, Canada
DermEffects
London, Ontario, Canada
North York Research Inc.
North York, Ontario, Canada
The Centre for Dermatology
Richmond Hill, Ontario, Canada
York Dermatology
Richmond Hill, Ontario, Canada
Toronto Research Centre
Toronto, Ontario, Canada
Research Toronto
Toronto, Ontario, Canada
AvantDerm
Toronto, Ontario, Canada
XLR8 Clinical Research
Windsor, Ontario, Canada
Clinique D
Laval, Quebec, Canada
Beijing Children's Hospital, Capital Medical University
Beijing, China
Peking University third hospital
Beijing, China
Peking union medical college hospital
Beijing, China
Children's Hospital Capital Institute of Pediatrics
Beijing, China
The Third Xiangya Hospital of Central South University
Changsha, China
Chongqing Traditional Chinese medicine Hospital
Chongqing, China
First affiliated hospital of chongqing medical university
Chongqing, China
The Southwest Hospital of AMU
Chongqing, China
Zhejiang province People's Hospital
Hangzhou, China
Dermatology hospital of Shanghai
Shanghai, China
Huashan Hospital Affiliated to Fudan University
Shanghai, China
The first hospital of China medical university
Shenyang, China
First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
The second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Peking University People's Hospital
Beijing, Beiing, China
First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Zhongshan Hospital, Fudan University(Xiamen Branch)
Xiamen, Fujian, China
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
Guangdong Province Traditional Chinese Medical Hospital
Guangzhou, Guangdong, China
The First affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Wuhan No.1 Hospital
Wuhan, Hubei, China
Xiangya Hospital of Central South University
Changsha, Hunan, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Hospital for Skin Diseases, Chinese Academy of medical sciences
Nanjing, Jiangsu, China
Jiangsu province people's hospital
Nanjing, Jiangsu, China
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.